New PTSD drug shows promise in Large-Scale trial

NCT ID NCT07456696

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether a new drug called TSND-201 can safely reduce PTSD symptoms in adults. About 300 people with PTSD will receive either one of two doses of TSND-201 or a placebo once a week for 4 weeks, then be followed for 8 more weeks. The goal is to see if the drug helps lower the severity of PTSD symptoms.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for POST-TRAUMATIC STRESS DISORDER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • ATP Clinical Research

    RECRUITING

    Orange, California, 92866, United States

  • Accel Clinical Research

    RECRUITING

    Maitland, Florida, 32751, United States

  • Arch Clinical Trials

    RECRUITING

    Creve Coeur, Missouri, 63141, United States

  • Austin Clinical Trial Partners

    RECRUITING

    Austin, Texas, 78737, United States

  • Bio Behavioral Health

    RECRUITING

    Toms River, New Jersey, 08755, United States

  • CNS Healthcare

    RECRUITING

    Jacksonville, Florida, 32256, United States

  • CNS Healthcare

    RECRUITING

    Orlando, Florida, 32801, United States

  • CalNeuro Research Group

    RECRUITING

    Los Angeles, California, 90025, United States

  • Catalina Research Institute

    RECRUITING

    Montclair, California, 91763, United States

  • Cedar Clinical Research

    RECRUITING

    Draper, Utah, 84020, United States

  • Center for Emotional Fitness/ Lumina Clinical Research Center

    RECRUITING

    Cherry Hill, New Jersey, 08002, United States

  • Del Sol Research

    RECRUITING

    Tucson, Arizona, 85715, United States

  • DelRicht - New Orleans

    RECRUITING

    New Orleans, Louisiana, 70115, United States

  • Elevate Clinical Research

    RECRUITING

    Houston, Texas, 77058, United States

  • Excell Research

    RECRUITING

    Oceanside, California, 92056, United States

  • Flourish Research

    RECRUITING

    Plymouth Meeting, Pennsylvania, 19462, United States

  • Global Medical Institutes

    RECRUITING

    Princeton, New Jersey, 08540, United States

  • Haracec Clinical Research

    RECRUITING

    El Paso, Texas, 79902, United States

  • Headlands Research - Pharmasite

    RECRUITING

    Pikesville, Maryland, 21208, United States

  • Inland Psychiatric Medical Group

    RECRUITING

    San Juan Capistrano, California, 92675, United States

  • Inner Space Research

    RECRUITING

    Orem, Utah, 84058, United States

  • Insight Clinical Trials

    RECRUITING

    Independence, Ohio, 44131, United States

  • Kadima Neuropsychiatry

    RECRUITING

    La Jolla, California, 92037, United States

  • Medical Research Network

    RECRUITING

    New York, New York, 10128, United States

  • Midwest Research Group

    RECRUITING

    Saint Charles, Missouri, 63304, United States

  • Preferred Research Partners

    RECRUITING

    Little Rock, Arkansas, 72211, United States

  • Seattle Neuropsychiatric Treatment Center (NTC)

    RECRUITING

    Seattle, Washington, 98104, United States

  • Segal Trials

    RECRUITING

    Lauderhill, Florida, 33319, United States

  • Starlight Clinical Research

    RECRUITING

    Evergreen, Colorado, 80439, United States

    Contact Email: •••••@•••••

  • Suburban Research Associates

    RECRUITING

    West Chester, Pennsylvania, 19380, United States

    Contact Email: •••••@•••••

  • Uptown Research Institute

    RECRUITING

    Chicago, Illinois, 60640, United States

  • Vitalix Clinical

    RECRUITING

    Worcester, Massachusetts, 01608, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.